Data is not available at this time.
Jiangsu Hengxing New Material operates as a specialized chemical producer focused on the research, development, and manufacturing of diverse organic compounds including ketones, acids, esters, alcohols, aldehydes, ethers, and acid anhydrides. The company serves global markets from its base in Jiangsu, China, positioning itself within the competitive basic materials sector. Its revenue model centers on producing and selling these high-purity chemical intermediates to various industrial customers who utilize them as essential inputs for pharmaceuticals, agrochemicals, coatings, and other downstream applications. Hengxing's market position reflects that of a niche chemical manufacturer competing on product quality, technical expertise, and production efficiency rather than scale. The company operates in a capital-intensive industry where technological capabilities and environmental compliance are critical success factors, requiring continuous investment in R&D and production facilities to maintain competitiveness.
The company generated CNY 730.3 million in revenue with net income of CNY 34.9 million, reflecting a net margin of approximately 4.8%. Operating cash flow of CNY 36.3 million indicates reasonable cash conversion from operations. The modest profitability suggests competitive market conditions and potential margin pressures typical in the chemical intermediates sector.
Diluted EPS of CNY 0.17 demonstrates modest earnings generation relative to the share base. The negative capital expenditures of CNY 118.4 million indicate significant investment in productive capacity, suggesting the company is prioritizing growth and operational expansion over immediate earnings optimization.
The balance sheet shows strong liquidity with CNY 194.2 million in cash against minimal total debt of CNY 18.5 million, indicating a conservative financial structure. The low debt-to-equity ratio provides financial flexibility and resilience, though the substantial cash position may suggest underutilized capital for a growing enterprise.
The company maintains a dividend policy with CNY 0.125 per share distribution, indicating commitment to shareholder returns despite its growth investments. The significant capital expenditure program suggests management is prioritizing capacity expansion and operational enhancements to drive future revenue growth.
With a market capitalization of CNY 3.7 billion, the company trades at approximately 5.1 times revenue and 106 times earnings, reflecting growth expectations. The beta of 1.46 indicates higher volatility than the market, typical for smaller chemical companies with cyclical exposure.
The company's strategic position lies in its specialized chemical expertise and production capabilities within specific organic compound segments. Future success will depend on maintaining technological competitiveness, managing input cost volatility, and effectively deploying its expansion investments to capture market opportunities while navigating regulatory and environmental requirements.
Company financial reportsStock exchange disclosuresMarket data providers
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |